Sino Medical Sciences Technology In (688108) — Cash Flow Reinvestment Rate

Latest as of September 2025: 0.21x

Sino Medical Sciences Technology In (688108) has a Cash Flow Reinvestment Rate of 0.21x as of September 2025, reinvesting CN¥6.63 Million (capex CN¥6.63 Million ) from operating cash flow of CN¥31.52 Million. See Sino Medical Sciences Technology In free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.21x
(Capex + Investments) / Operating CF

Total Reinvested

CN¥6.63 Million
Capex + Investments

Operating Cash Flow

CN¥31.52 Million
CNY

Capital Expenditures

CN¥6.63 Million
CNY

Sino Medical Sciences Technology In Cash Flow Reinvestment Rate (2016–2025)

Historical reinvestment intensity for Sino Medical Sciences Technology In across 8 annual periods. For the full cash flow conversion analysis, see 688108 cash generation efficiency.

Annual Cash Flow Reinvestment Rate for Sino Medical Sciences Technology In (2016–2025)

Year-by-year capital reinvestment analysis for Sino Medical Sciences Technology In. See how financially flexible is Sino Medical Sciences Technology In to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (CNY) Operating CF Capex YoY Change
2025 0.28x CN¥45.80 Million CN¥161.87 Million CN¥45.80 Million ▼ -47.0%
2024 0.53x CN¥70.09 Million CN¥131.24 Million CN¥70.02 Million ▼ -88.4%
2023 4.59x CN¥260.71 Million CN¥56.84 Million CN¥67.67 Million ▲ +174.6%
2020 1.67x CN¥117.78 Million CN¥70.51 Million CN¥112.78 Million ▲ +24.2%
2019 1.34x CN¥185.04 Million CN¥137.61 Million CN¥180.04 Million ▼ -63.4%
2018 3.68x CN¥358.87 Million CN¥97.56 Million CN¥98.87 Million ▼ -23.0%
2017 4.78x CN¥336.00 Million CN¥70.32 Million CN¥76.25 Million ▲ +131.5%
2016 2.06x CN¥87.19 Million CN¥42.24 Million CN¥44.32 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow